GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues

Tehnologie

Education As recent studies show the amount of people taking glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss , and not for managing type 2 diabetes as originally used, researchers have been examining these medications for potential positive and negative side effects. Examples of GLP-1 medications include Ozempic , Wegovy , Mounjaro , and Zepbound . For example, a study published in October 2023 found that the use of GLP-1 drugs for weight loss was associated with an

GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues https://www.medicalnewstoday.com - 21.01.2025 19:23

din zilele anterioare

GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues https://www.medicalnewstoday.com - 21.01.2025 19:23